Groves Regina E
- SEC CIK
- 0001653877
In the past year, 1 open-market sale filing worth $288.1K and no purchases.
Current role at each company
- ATRC AtriCure, Inc.Directoras of Sep 14, 2026
- FLGT Fulgent Genetics, Inc.Directoras of May 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $288.1K
- 1 filing
- Net
- −$288.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Groves Regina E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATRC AtriCure, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)5:44 PM ET | Sep 11 | 3 days | Groves Regina EDirector | SSale | −5.31K | $54.22 | −$288.1K | −13.3%34.5K after | |
| Aug 8, 2025 (view filing) | Aug 6 | 2 days | Groves Regina EDirector | SSale | −2.45K | $36.82 | −$90.3K | −6.8%33.7K after | |
| Oct 29, 2021 (view filing) | Apr 30 | 182 daysLate | Groves Regina EDirector | PPurchase | +34 | $76.68 | +$2.61K | +0.2%16.2K after | |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Groves Regina EDirector | SSale | −3.16K | $74.73 | −$235.8K | −16.3%16.2K after |